>>CEO SUMMARY: Clinical labs developing innovative tests face a challenge getting paid. While Medicare may reimburse for these tests, some commercial payers and state Medicaid programs are not paying for new proprietary laboratory analyses (PLA) codes and multianalyte assays with algorithmic analyses (MAAA) codes. For labs running these tests, experts say the codes themselves bias …
Insurers Are Rejecting Many PLA, MAAA Codes Read More »
